Rituximab Monotherapy for EBV-HLH and CAEBV
Condition(s):Secondary Hemophagocytic Lymphohistiocytosis; Chronic Active Epstein-Barr Virus InfectionLast Updated:May 20, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Secondary Hemophagocytic Lymphohistiocytosis; Chronic Active Epstein-Barr Virus InfectionLast Updated:May 20, 2022Recruiting
Condition(s):Secondary Hemophagocytic Lymphohistiocytosis; Chronic Active Epstein-Barr Virus InfectionLast Updated:May 3, 2023Recruiting
Condition(s):Chronic Active Epstein-Barr VirusLast Updated:December 19, 2023Recruiting
Condition(s):Chronic Active Epstein-Barr Virus Infection; Virus-Associated Hemophagocytic SyndromeLast Updated:June 27, 2023Recruiting
Condition(s):EBV InfectionLast Updated:February 10, 2021Recruiting
Condition(s):EBV InfectionLast Updated:January 5, 2022Unknown status
Condition(s):Epstein-Barr Virus InfectionsLast Updated:January 18, 2020Completed
Condition(s):EBV InfectionLast Updated:September 9, 2021Unknown status
Condition(s):Hodgkins Lymphoma; Non-Hodgkin LymphomaLast Updated:May 24, 2012Terminated
Condition(s):Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Myelodysplastic Syndromes; Chronic Myeloid Leukemia; Hemophagocytic Lymphohistiocytoses; Primary Immunodeficiency Diseases; Hemoglobinopathies; Severe Aplastic Anemia; Cytopenia; Bone Marrow Failure Syndrome; Severe Chronic Active Epstein-Barr Virus InfectionLast Updated:January 18, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.